The United States Cephalosporin Market accounts for the largest share in North America, supported by its advanced healthcare system, high prescription rates for antibacterial therapies, and strong presence of leading pharmaceutical manufacturers. Rising incidences of hospital-acquired and community-acquired bacterial infections, coupled with increasing demand for effective antimicrobial...